This Week in Science

In this week's Science, a Memorial Sloan Kettering Cancer Center-led team reports new insights into the genomic determinants of immune checkpoint inhibitors, a new class of drugs that use a patient's own T cells to attack cancer. Using whole-exome sequencing of non-small cell lung cancers treated with the antibody pembrolizumab, the researcher found higher nonsynonymous mutation burden in tumors was associated with better responses to treatment.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Labs in the US and South Korea are hoping to bring the woolly mammoth back from beyond extinction, Newsweek writes.

Geneticist Adam Rutherford speaks with National Geographic about paleogenetics, race, and more.

Researchers link genetic links between education and smoking and longevity.

In PNAS this week: influence of gene environment interactions on polygenic traits, epigenetic features affecting fruit fly foraging, and more.